Oncotrap, Inc.

OncoTrap Inc. develops medicine that induces the immune response as a means to eradicate tumor burden. The development of the product is achieved by the teamwork of biotechnologists, formulation scientists, pharmacological scientists, analytical chemists and professionals that have a profound understanding of industrial pharmaceutics.